Market Size of Global Electromyography Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 10.10 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Electromyography Devices Market Analysis
The electromyography devices market is expected to record a CAGR of 10.1% over the forecast period.
COVID-19 had a notable impact on the overall healthcare industry. As per the article published in 2021 under the title 'Musculoskeletal involvement of COVID-19: a review of imaging', myalgia was a common clinical feature of COVID-19. Moreover, there were reports of a variety of neuromuscular and rheumatologic side effects, such as myositis, neuropathy, arthropathy, and soft tissue abnormalities, that are linked to COVID-19 infection and disease progression. As musculoskeletal abnormalities boosted during the pandemic, diagnostic tests were adopted in a high proportion. Hence, COVID-19 had a significant impact on the electromyography devices market.
The increasing prevalence of neuromuscular disorders, such as motor neuron diseases, myasthenia gravis, myopathy, Parkinson's disease, peripheral neuropathy, and amyotrophic lateral sclerosis, and the surge in minimally invasive surgeries are expected to drive the market growth. For instance, as per the article published in 2020 under the title 'The prevalence of hereditary neuromuscular disorders in Northern Norway', the survey conducted showed that total prevalence was higher in hereditary neuromuscular disorders than previously hypothesized in European population-based studies. 542 people in Northern Norway had a genetic neuromuscular condition as of January 2020. The prevalence was especially high for myotonia congenita and limb-girdle muscular dystrophy. In addition, according to the Parkinson's Disease Foundation 2022 update, approximately 60,000 Americans are diagnosed with Parkinson's Disease (PD) each year. The increasing prevalence of this disease is anticipated to propel market growth over the forecast period.
Technological advancements in electromyography (EMG) systems and the growing demand for portable EMG devices to curb the rising hospital and healthcare-associated costs are the key drivers that are likely to fuel market growth. For instance, advancements in technologies, such as the RS-EMGx EMG System, which enables 4 channels of EMG recordings simultaneously from a single subject, are likely to boost the market growth.
As per the aforementioned factors, the electromyography devices market is anticipated to grow over the forecast period. However, biocompatibility issues with medical electrodes restrain the market growth.
Electromyography Devices Industry Segmentation
As per the scope of the report, electromyography (EMG) is a diagnostic procedure to assess the health of muscles and the nerve cells that control them (motor neurons). It is used for the evaluation of the health condition of muscles and nerve cells that are responsible for controlling the muscles. An EMG translates signals into numbers or graphs, aiding doctors to diagnose. The Electromyography Devices Market is segmented by Product Mobility (Stationary EMG Systems and Portable EMG Systems), Study Type (Nerve Conduction and Evoked Potential), Product Type (EMG Type, Software, Electrode, Other Products) Application (Muscular Disorders, Neuro Disorders, Neuromuscular disorders, Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally.
| By Product Mobility | |
| Stationary EMG Systems | |
| Portable EMG Systems |
| By Study Type | |
| Nerve Conduction | |
| Evoked Potential |
| By Product | ||||
| ||||
| Software | ||||
| Electrode | ||||
| Other Products |
| By Application | |
| Muscular Disorders | |
| Neuro Disorders | |
| Neuromuscular disorders | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Electromyography Devices Market Size Summary
The electromyography devices market is poised for significant growth, driven by the increasing prevalence of neuromuscular disorders and the rising demand for minimally invasive surgeries. The impact of COVID-19, which highlighted musculoskeletal abnormalities and led to a surge in diagnostic tests, has further propelled the adoption of electromyography devices. Technological advancements, such as the development of portable EMG systems, are also contributing to market expansion by offering cost-effective solutions for remote patient monitoring and chronic disease management. Despite challenges like biocompatibility issues with medical electrodes, the market is expected to grow steadily over the forecast period.
North America currently leads the electromyography devices market, supported by high awareness of muscular and neurological disorders and favorable government policies. The region benefits from robust healthcare infrastructure and initiatives that promote research and development in neuromuscular disorder treatments. The market is characterized by a fragmented landscape with several global and regional players, including Natus Medical Incorporated, ADInstruments, and Delsys Incorporated. These companies are actively involved in innovation and product development, further driving market growth. As the demand for advanced and portable EMG devices continues to rise, the market is anticipated to maintain its upward trajectory.
Global Electromyography Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Mascular and Neurological Disorders
-
1.2.2 Rising Focus Toward Minimally Invasive Surgeries
-
1.2.3 Technological Advancements in Medical Electrodes
-
-
1.3 Market Restraints
-
1.3.1 Biocompatibility Issues with Medical Electrodes
-
1.3.2 Stringent Regulatory Guidelines Associated with Medical Electrodes
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
2.1 By Product Mobility
-
2.1.1 Stationary EMG Systems
-
2.1.2 Portable EMG Systems
-
-
2.2 By Study Type
-
2.2.1 Nerve Conduction
-
2.2.2 Evoked Potential
-
-
2.3 By Product
-
2.3.1 EMG Type
-
2.3.1.1 Surface EMG
-
2.3.1.2 Intramuscular EMG
-
-
2.3.2 Software
-
2.3.3 Electrode
-
2.3.4 Other Products
-
-
2.4 By Application
-
2.4.1 Muscular Disorders
-
2.4.2 Neuro Disorders
-
2.4.3 Neuromuscular disorders
-
2.4.4 Other Applications
-
-
2.5 Geography
-
2.5.1 North America
-
2.5.1.1 United States
-
2.5.1.2 Canada
-
2.5.1.3 Mexico
-
-
2.5.2 Europe
-
2.5.2.1 Germany
-
2.5.2.2 United Kingdom
-
2.5.2.3 France
-
2.5.2.4 Italy
-
2.5.2.5 Spain
-
2.5.2.6 Rest of Europe
-
-
2.5.3 Asia-Pacific
-
2.5.3.1 China
-
2.5.3.2 Japan
-
2.5.3.3 India
-
2.5.3.4 Australia
-
2.5.3.5 South Korea
-
2.5.3.6 Rest of Asia-Pacific
-
-
2.5.4 Middle East and Africa
-
2.5.4.1 GCC
-
2.5.4.2 South Africa
-
2.5.4.3 Rest of Middle East and Africa
-
-
2.5.5 South America
-
2.5.5.1 Brazil
-
2.5.5.2 Argentina
-
2.5.5.3 Rest of South America
-
-
-
Global Electromyography Devices Market Size FAQs
What is the current Global Electromyography Devices Market size?
The Global Electromyography Devices Market is projected to register a CAGR of 10.10% during the forecast period (2024-2029)
Who are the key players in Global Electromyography Devices Market?
Natus Medical Incorporated , ADInstruments, Delsys Incorporated , iWorx and Ambu A/S are the major companies operating in the Global Electromyography Devices Market.
